Eli Lilly Loses Full Fed. Circ. Bid To Nix Teva's $177M IP Win
Federal Circuit judges Wednesday denied Eli Lilly & Co.'s bid for a full court review of a panel decision that reinstated a $177 million jury verdict against it for infringing Teva...To view the full article, register now.
Already a subscriber? Click here to view full article